Koers Celsion Corporation Nasdaq
Aandelen
US15117N4043
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
13/05 | Transcript : Imunon, Inc., Q1 2024 Earnings Call, May 13, 2024 | |
08/05 | IMUNON, Inc. Benoemt Stacy R. Lindborg tot Chief Executive Officer, met ingang van 13 mei 2024 | CI |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 13,25 mln. 12,2 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -20 mln. -18,4 mln. | Nettowinst (verlies) 2025 * | -25 mln. -23 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-0,72
x | K/w-verhouding 2025 * |
-0,55
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,84% |
Recentste transcriptie over Celsion Corporation
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Stacy Lindborg
CEO | Chief Executive Officer | 53 | 04-06-21 |
Michael Tardugno
CHM | Chairman | 73 | 03-01-07 |
Jeffrey Church
DFI | Director of Finance/CFO | 67 | 06-07-10 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 56 | 08-06-21 | |
Frederick Fritz
BRD | Director/Board Member | 73 | 08-07-11 |
James Dentzer
BRD | Director/Board Member | 57 | 03-09-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,68% | 113 mld. | |
+10,36% | 106 mld. | |
+0,41% | 22,27 mld. | |
-11,95% | 22,22 mld. | |
-5,99% | 19,43 mld. | |
-37,36% | 17,87 mld. | |
-5,22% | 17,24 mld. | |
+6,66% | 14,29 mld. | |
+36,23% | 12,52 mld. |
- Beurs
- Aandelen
- Koers IMNN
- Koers